TLR4 and gram-positive bacterial infections: Subsequently, the Toll signalling pathway was implicated in host resistance against fungal and Gram-positive bacterial infections [10–12], which triggers in the fat body the production of antimicrobial peptides (AMPs), among which the antifungal peptide Drosomycin (Drs) appears to be the principal target of the Toll pathway [10,13].